Search clinical trials for: Interleukin 12p70

Total 1560 results

Inge Marie Svane

Completed

T-cell Based Immunotherapy for of Melanoma

Melanoma

Denmark
Beijing 302 Hospital

Unknown

Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection

Chronic Hepatitis C

China
Novartis Pharmaceuticals

Completed

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Germany, United States, Belgium, Russian Federation, United Kingdom
Peking University Cancer Hospital & Institute

Completed

Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion (GMPE)

Breast Neoplasms | Neoplasm Metastasis | Immunotherapy | Gene Expression Profiling

China
University Hospital Tuebingen

Completed

A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2

Malignant Melanoma

Germany
Eli Lilly and Company

Completed

Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Inflammatory Arthritis

Bulgaria, Georgia, Moldova, Republic of, Romania
University of Utah

Completed

A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Recurrent Renal Cell Carcinoma | Stage IV Renal Cell Cancer

United States
Cambridge University Hospitals NHS Foundation Trust
Juvenile Diabetes Research Foundation; Wellcome Trust; University of Cambridge; National Institute for Health Research, United Kingdom

Completed

Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2 (DILT1D)

Type 1 Diabetes

United Kingdom
Ohio State University

Completed

Effect of Root Canal Treatment (Versus no Treatment) for Patients With Tooth Infections and Toothaches

Postoperative Pain

United States
Vertex Pharmaceuticals Incorporated

Terminated

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype (CONCISE)

Hepatitis C, Chronic

United States, Austria, Canada, Germany, Israel, Poland
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic... and other conditions

United States
City of Hope Medical Center

Completed

Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2

Glioblastoma | Brain Tumor | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Ependymoma | Anaplastic Oligodendroglioma | Giant Cell Glioblastoma | Anaplastic Meningioma | Mixed Glioma | Brain Stem Glioma | Ependymoblastoma | Grade III Meningioma | Meningeal Hemangiopericytoma | Pineal Gland Astrocytoma

United States
University of Athens

Completed

Anakinra in Hidradenitis Suppurativa

Hidradenitis Suppurativa

Greece
Philogen S.p.A.

Completed

Intratumoral Administration of L19IL2/L19TNF

Malignant Melanoma, Skin

Italy
National Institute of Allergy and Infectious Diseases...

Completed

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

HIV Infections

United States
M.D. Anderson Cancer Center

Completed

Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Leukemia | Myelodysplastic Syndrome

United States
National Cancer Institute (NCI)

Completed

Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular Lymphoma

Lymphoma

United States
National Cancer Institute (NCI)

Completed

Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

Melanoma (Skin)

United States
National Cancer Institute (NCI)

Completed

Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institute on Aging (NIA)
National Cancer Institute (NCI)

Completed

Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

Lymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Melbourne Health
The Intensive Care Unit Departmental Funding

Withdrawn

Interleukin-4 (IL-4) as a Marker of Atherosclerosis

Atherosclerosis | Ischemic Heart Disease
INSYS Therapeutics Inc
National Institutes of Health (NIH)

Terminated

Possible New Therapy for Advanced Cancer

Adrenocortical Carcinoma

United States
Hadassah Medical Organization

Completed

The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2

Metastatic Melanoma

Israel
Centocor, Inc.

Completed

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Psoriasis
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic... and other conditions

United States
Northwestern University
National Cancer Institute (NCI)

Completed

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Kidney Cancer | Melanoma (Skin)

United States
Interleukin Genetics, Inc.

Completed

Identification of Gene Biomarkers in Aging Skin

Hyperpigmentation | Skin Aging

Japan
Southwest Oncology Group
National Cancer Institute (NCI); Eastern Cooperative Oncology Group; Children... and other collaborators

Completed

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Melanoma (Skin)

United States, Australia
Icahn School of Medicine at Mount Sinai

Completed

Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency

Common Variable Immunodeficiency
Istanbul Medeniyet University

Completed

Roles of T Helper 1 Cytokines in Type 1 Diabetes

Type 1 Diabetes

Turkey
National Institute of Allergy and Infectious Diseases...
Agouron Pharmaceuticals; Glaxo Wellcome; Chiron Corporation

Completed

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

HIV Infections

United States
Bristol-Myers Squibb

Completed

Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors

Neoplasms by Site

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Neuroblastoma

United States, Canada
Centre Leon Berard
Ministry of Health, France; Cytheris, Inc.

Completed

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Metastatic Breast Cancer

France
Instituto Mexicano del Seguro Social

Completed

Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney

Renal Insufficiency

Mexico
National Cancer Institute (NCI)

Terminated

Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma

Skin Cancer | Metastatic Melanoma

United States
Bayer

Completed

Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection

HIV Infections

France, United States, United Kingdom
University of Virginia
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
University of Zurich

Completed

Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study

Postprandial Fatigue

Switzerland
Shanghai Children's Medical Center
Xiamen Amoytop Biotech Co., Ltd.

Completed

Effect of rhIL-11 in Patients With Thrombocytopenia for Childhood ALL

Pancytopenia Due to Chemotherapy

China
University of Athens

Completed

Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery Disease

Coronary Artery Disease | Inflammation | Rheumatoid Arthritis

Greece
University of Alabama at Birmingham

Terminated

Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma

Neuroblastoma

United States
University of Aarhus
Danish Renal Cancer Study Group

Unknown

Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer

Metastatic Renal Cell Carcinoma

Denmark
Juan A. Arnaiz

Completed

Intermittent ART in Primary HIV Infection (PHI-IL2)

HIV

Spain
Universidad Autonoma de San Luis Potosí
Hospital Central "Dr. Ignacio Morones Prieto"

Completed

Inflammation in Melasma: Study of Its Infiltrate and the Expression of Acute and Chronic Mediators

Melasma

Mexico
Philogen S.p.A.

Completed

Intratumoral Application of L19IL2 in Patients With Malignant Melanoma

Malignant Melanoma

Austria, Germany

Search clinical trials for: Interleukin 12p70

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations